Occurrence of NDM-1, VIM-1, and OXA-10 Co-Producing Providencia rettgeri Clinical Isolate in China
Siquan Shen,Xiangning Huang,Qingyu Shi,Yan Guo,Yang Yang,Dandan Yin,Xun Zhou,Li Ding,Renru Han,Hua Yu,Fupin Hu
DOI: https://doi.org/10.3389/fcimb.2021.789646
IF: 6.073
2022-01-03
Frontiers in Cellular and Infection Microbiology
Abstract:Providencia rettgeri is a nosocomial pathogen associated with urinary tract infections related to hospital-acquired Infections. In recent years, P. rettgeri clinical strains producing New Delhi Metallo-β-lactamase (NDM) and other β-lactamase which reduce the efficiency of antimicrobial therapy have been reported. However, there are few reports of P. rettgeri co-producing two metallo-β-lactamases in one isolate. Here, we first reported a P. rettgeri strain (P138) co-harboring bla NDM-1 , bla VIM-1 , and bla OXA-10 . The specie were identified using MALDI-TOF MS. The results of antimicrobial susceptibility testing by broth microdilution method indicated that P. rettgeri P138 was resistant to meropenem (MIC = 64μg/ml), imipenem (MIC = 64μg/ml), and aztreonam (MIC = 32μg/ml). Conjugation experiments revealed that the bla NDM-1 -carrying plasmid was transferrable. The carbapenemase genes were detected using PCR and confirmed by PCR-based sequencing. The complete genomic sequence of the P. rettgeri was identified using Illumina (Illumina, San Diego, CA, USA) short-read sequencing (150bp paired-end reads), and many common resistance genes had been identified, including bla NDM-1 , bla VIM-1 , bla OXA-10 , aac(6’)-Il, aadA5, ant(2’’)-Ia, aadA1, aac(6’)-Ib3, aadA1, aph(3’)-Ia, aac(6’)-Ib-cr , qnrD1 , qnrA1 , and catA2 . The bla NDM-1 gene was characterized by the following structure: IS 110 –TnpA–IntI1–aadB–IS 91 –GroEL–GroES–DsbD–PAI–ble– bla NDM-1 –IS 91 –QnrS1–IS 110 . Blast comparison revealed that the bla NDM-1 gene structure shared >99% similarity with plasmid p5_SCLZS62 (99% nucleotide identity and query coverage). In summary, we isolated a P. rettgeri strain coproducing bla NDM-1 , bla VIM-1 , and blaOXA-10. To the best of our acknowledge, this was first reported in the world. The occurrence of the strain needs to be closely monitored.
immunology,microbiology